The nation's largest pharmacy benefits manager is throwing its weight into a fight over the high cost of treating hepatitis C, saying it will cover a drug from AbbVie while pulling back on those from rival drugmakers.
The Associated Press, San Diego Union-Tribune Nation
Mon, 12/22/2014 - 5:52am